Aurora Cannabis (ACB)
(Delayed Data from NSDQ)
$6.24 USD
+0.49 (8.43%)
Updated Jul 22, 2024 03:59 PM ET
After-Market: $6.24 +0.01 (0.08%) 4:42 PM ET
4-Sell of 5 4
C Value B Growth B Momentum B VGM
Aurora Cannabis Inc. (ACB) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$5.70 | $8.03 | $3.67 | -0.87% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Aurora Cannabis Inc. comes to $5.70. The forecasts range from a low of $3.67 to a high of $8.03. The average price target represents a decline of 0.87% from the last closing price of $5.75.
Analyst Price Targets (5 )
Broker Rating
Aurora Cannabis Inc. currently has an average brokerage recommendation (ABR) of 2.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 2.67 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, one is Strong Buy, representing 16.67% of all recommendations. A month ago, Strong Buy represented 16.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.67 | 2.67 | 2.67 | 2.67 | 2.67 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/25/2024 | Roth Capital Partners | William Kirk | Hold | Hold |
6/21/2024 | Canaccord Genuity | Matt Bottomley | Strong Buy | Strong Buy |
6/3/2024 | ATB Capital Markets | Frederico Gomes | Hold | Hold |
2/27/2024 | Not Identified | Not Identified | Hold | Hold |
2/21/2024 | CIBC World Markets Corp. | John Zamparo | Hold | Hold |
10/2/2023 | BMO Capital Markets | Tamy Chen | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.67 |
ABR (Last week) | 2.67 |
# of Recs in ABR | 6 |
Average Target Price | $5.70 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 76 of 252 |
Current Quarter EPS Est: | -0.19 |